Yamauchi, M.; Maekawa, M.; Sato, T.; Sato, Y.; Kumondai, M.; Tsuruoka, M.; Inoue, J.; Masamune, A.; Mano, N.
Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites 2024, 14, 513.
https://doi.org/10.3390/metabo14090513
AMA Style
Yamauchi M, Maekawa M, Sato T, Sato Y, Kumondai M, Tsuruoka M, Inoue J, Masamune A, Mano N.
Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites. 2024; 14(9):513.
https://doi.org/10.3390/metabo14090513
Chicago/Turabian Style
Yamauchi, Minami, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, and Nariyasu Mano.
2024. "Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma" Metabolites 14, no. 9: 513.
https://doi.org/10.3390/metabo14090513
APA Style
Yamauchi, M., Maekawa, M., Sato, T., Sato, Y., Kumondai, M., Tsuruoka, M., Inoue, J., Masamune, A., & Mano, N.
(2024). Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites, 14(9), 513.
https://doi.org/10.3390/metabo14090513
